Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Technology & End-User The global breast imaging market will witness a robust CAGR of 8.73%, valued at $4.14 billion in 2021, expected to appreciate and reach $8.79 billion by 2030, confirms Strategic Market Research. Key Industry Drivers - Rising prevalence of breast cancer and technological advancements The continuous increase in the number of breast cancers is one of the essential factors that is propelling the growth of the breast imaging market significantly. According to WHO, in 2020, there were 2.3 Mn women diagnosed with breast cancer, and 685 000 deaths occurred globally. By the end of the year 2020, there were 7.8 Mn women alive who had been diagnosed with breast cancer in the last 5 years, thus making it one of the world's most prevalent types of cancer. Also, according to Breast Cancer.org, about 43,300 women in the U.S. are expected to die in 2022 due to breast cancer. The mortality rates have been steady among women under 50 since 2007 but have continued to drop among women over 50 years of age. The overall rate of death from breast cancer decreased by 1% each year from 2013 to 2018. These decreases are presumed to result from advanced treatment and earlier detection through screening processes. As of January 2021, there were more than 3.8 Mn women with a history of breast cancer in the U.S, including women who are currently being treated and women who have already finished their treatment. The rise in the number of breast cancer cases worldwide has led to the increase in the usage of a variety of breast screenings processes (breast MRI, breast tomosynthesis, Molecular breast imaging, Positron emission mammography, Contrast-enhanced mammography, Electrical impedance imaging, Elastography, gynecomastia ultrasound, mastitis ultrasound, breast sonogram, gynecomastia radiology, galactocele radiology, fibroadenoma radiology, fibrocystic breast disease radiology, breast cancer radiology) which is also fuelling the overall market growth. According to the U.S. FDA (Food and Drug Administration), 40 Mn mammograms are performed yearly in the United States. Mammography is considered one of the best methods for screening women for breast cancers. Furthermore, rapid technological advancements in breast screening, a rising number of conferences worldwide on spreading awareness regarding the benefits of early screening and diagnosis, the rise of government and private investments to meet the increasing demand for breast cancer screening, and the excellent cancer screening reimbursement policies are widely augmenting the market's growth globally. Breast Imaging Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 4.14 billion The revenue forecast in 2030 USD 8.79 billion Growth rate CAGR of 8.73 % The base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation Based on Technology, Based on End-User, and By region. Based on Technology Ionizing Breast Imaging (Mammography, Molecular Breast Imaging (MBI), Positron Emission Tomography-Computed Tomography (PET-CT), Cone-beam Computed Tomography (CBCT), Positron Emission Mammography (PEM) Non-ionizing Breast Imaging(Breast Ultrasound, Automated whole-breast Ultrasound (AWBU), Breast MRI, Electric Impedance Tomography, Breast thermography, Optical Imaging). Based on End-User Hospitals & Clinics, Diagnostic Imaging Centers, Breast Care Centers. By Region North America, Europe, Asia-Pacific, and LAMEA Country Scope US, Mexico, Canada, Germany, UK, France, China, Japan, India etc. Company Usability Profiles Hologic Inc., Siemens Healthineers, GE Healthcare, Fujifilm Holdings Corporation, Canon Inc., Koninklijke Philips N.V., Aurora Healthcare US Corp., Allengers, Dilon Technologies, Inc., Planmed Oy, Delphinus Medical Technologies Inc., CMR Naviscan Corporation, Micrima Limited, SuperSonic Imagine, Carestream Health. Pricing and purchase options Customized buying options are available to meet your exact research needs. Restraints - Overdiagnosis and Overtreatment Overdiagnosis and overtreatment of breast cancer through mammography and repeated use of breast cancer screening technologies leading to a higher cost are some factors restraining the overall market growth. Opportunities - Rise of government funds for Breast Cancer Screening Governments all across the globe are now focusing on increasing the expenditure for breast cancer screenings worldwide. Along with that, the continuously improving reimbursement policies of breast cancer screenings and treatments are expected to present ample growth opportunities for the market players. Market Analysis Of Different Segments Covered in the Report Based on Technology Ionizing Breast Imaging Mammography o Full-field Digital Mammography (FFDM) o Analog Mammography o 3D Breast Tomosynthesis Molecular Breast Imaging (MBI) Positron Emission Tomography-Computed Tomography (PET-CT) Cone-beam Computed Tomography (CBCT) Positron Emission Mammography (PEM) Non-ionizing Breast Imaging Breast Ultrasound Automated whole-breast Ultrasound (AWBU) Breast MRI Electric Impedance Tomography Breast thermography Optical Imaging Based on End-User Hospitals & Clinics Diagnostic Imaging Centers Breast Care Centers Regional Coverage Analysis North America United States Mexico Canada Rest of North America Europe Switzerland Russia France Germany U.K Finland Turkey Netherlands Belgium Spain Italy Rest of Europe Asia Pacific China India Indonesia South Korea Thailand Japan Singapore Malaysia Philippines Australia New Zealand Rest of APAC LAMEA Brazil Saudi Arabia Uruguay Argentina Rest of LAMEA Based on Technology, the ‘Non-ionizing Breast Imaging’ segment dominated the market in 2020 with the highest CAGR during the estimated period. Various advantages offered by the non-ionizing breast imaging technologies, such as the detection of small breast lesions in women with dense breast tissues and the depth of anatomical details for diagnosis, are fuelling the overall market growth in this region. Among the ‘Non-ionizing Breast Imaging’ segment, the ‘Breast Ultrasound’ segment dominated the market comprehensively, with a total share of 58.71% of the entire breast imaging market and a CAGR of 11.18%. Factors like the lower risk of radiation exposure, the huge number of benefits offered by breast ultrasound, such as the ability to detect the direction of blood flow through vessels, and the capability to distinguish between a cyst and a solid mass are boosting the overall growth of this segment. Based on End-User, the ‘Hospitals & Clinics’ segment significantly dominated the market in 2020 with a steady CAGR value. The rise of government funds for breast cancer treatments and healthcare infrastructures, the higher rate of admissions of breast cancer patients in the hospitals, and the presence of highly-skilled surgeons are stimulating the entire growth of the market in this segment. Based on Region, North America dominated the entire market comprehensively with a total share of 39.47% of the entire market in 2020, owing to the continuous rising cases of breast cancers. According to National Breast Cancer Foundation, in 2020, an estimated 276,480 new cases of invasive breast cancer were detected in women in the United States. There were 48,530 new cases of non-invasive breast cancers. The Asia-Pacific region held the fastest growth rate with the highest CAGR value throughout the estimated period. The continuous rising prevalence of breast cancers, the rise of healthcare expenditures, the rise of awareness programs for detecting breast cancers early, and the massive government spending on breast cancer research studies in several APAC countries are the major factors that are fuelling the growth of the breast imaging market in the Asia Pacific. According to GLOBOCAN 2018, 911,014 new breast cancer cases were diagnosed in Asia, and the number is expected to rise by 229,650 by 2030. Breast Imaging Market Competitive Landscape Analysis A thorough competitive landscape analysis provides the most appropriate information about the crucial competitors in the breast imaging market environment. The comparison is performed based on various market initiatives, investment in R&D, company overview, total revenue generation, market potential, company strengths and weaknesses, company financials, global presence, production capacity, production sites, and facilities. Hologic Inc. Siemens Healthineers GE Healthcare Fujifilm Holdings Corporation Canon Inc. Koninklijke Philips N.V. Aurora Healthcare US Corp. Allengers Dilon Technologies, Inc. Planmed Oy Delphinus Medical Technologies Inc. CMR Naviscan Corporation Micrima Limited SuperSonic Imagine Carestream Health Recent Developments On December 2021, GE Healthcare announced that they are leveraging their USP of 3D Mammography and artificial intelligence to enhance breast cancer screening. The annual mammograms for early detection of breast cancer have made a huge difference in the lives of millions of women worldwide. Patient outcomes and accuracy will improve significantly with the incorporation of AI (artificial intelligence) and advanced technological imaging. On December 2020, Hologic added 3D Breast Ultrasound Imaging to the SuperSonic MACH 40 System. The system has a volumetric transducer that allows the users to easily acquire the 3D images with no resolution loss, regardless of where the lesion is situated within the breast. On March 2020, Siemens Healthineers introduced new solutions for mammography workflow optimization and breast image reading. The new Teamplay Mammo Dashboard accurately tracks and analyses the breast imaging workflows and identifies bottlenecks. Frequently Asked Question About This Report Which is the leading End-User segment of the market? Based on End-User, the Hospitals & Clinics segment dominated the market in 2020 significantly with a steady CAGR value. How big is the breast imaging market? The global breast imaging market size was $ 4.14 Bn in 2021 and is predicted to reach $ 8.79 Bn by 2030, with a CAGR of 8.73 %. What are the breast imaging market growth? 8.73 % from 2021 to 2030 to reach USD 8.79 Billion by 2030. Which is the most dominant Technology in the market? Based on Technology, the Non-ionizing Breast Imaging segment dominated the market in 2020 with the highest CAGR during the estimated period. What is the most dominant region of the market? Based on Region, North America dominated the entire market comprehensively with a total share of 39.47% of the entire market in 2020 owing to the continuous rising cases of breast cancers. Who are the most crucial players in the market? The most vital players of the market are Hologic Inc, Siemens Healthineers, GE Healthcare, Fujifilm Holdings Corporation, Canon Inc, Koninklijke Philips N.V, Aurora Healthcare US Corp, Allengers Dilon Technologies, Inc, Planmed Oy, Delphinus Medical Technologies Inc, CMR Naviscan Corporation, Micrima Limited, SuperSonic Imagine, and Carestream Health. Sources https://www.who.int/news-room/fact-sheets/detail/breast-cancer https://www.breastcancer.org/facts-statistics https://www.nationalbreastcancer.org/wp-content/uploads/2020-Breast-Cancer-Stats.pdf https://pubmed.ncbi.nlm.nih.gov/30207593/ 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Breast Imaging Market Snapshot 4.2 Global Market 4.2.1 Global Market, 2021 – 2028 (USD Million) 4.3 Regional Business Analysis 4.3.1 Global Market, by Region, 2021 - 2030 (USD Million) 4.4 End-User Business Analysis 4.4.1 Global Market, By End-User, 2021 - 2030 (USD Million) 4.5 Technology Business Analysis 4.5.1 Global Market, By Technology, 2021 - 2030 (USD Million) 4.6 Value Chain Analysis 4.7 Market Variable Analysis 4.7.1 Market Drivers Analysis 4.7.2 Market Restraints Analysis 4.8 Business Environment Analysis Tool 4.8.1 Market PEST analysis 4.8.2 Market Porter’s analysis 4.9 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Technology Analysis 5.11.1. Trends in Technology (2014-2021) 5.11.2. Trends in Technology (2021-2030) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By region, By Country) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Breast Imaging Manufacturing Sites, Area Served, End-User 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Global Market: By End-User Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Hospitals & Clinics 7.3.1. Hospitals & clinics Market, 2021 - 2030 (USD Million) 7.4. Diagnostic Imaging Centers 7.4.1. Diagnostic Imaging Centers Market, 2021 - 2030 (USD Million) 7.5 Breast Care Centers 7.5.1 Breast Care Centers market, 2021 - 2030 (USD Million) 8. Global Market: By Technology Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Ionizing Breast Imaging 8.3.1. Ionizing Market, 2021 - 2030 (USD Million) 8.3.1.1. Mammography market, 2021 - 2030 (USD Million) 8.3.1.1.1. Full-field Digital Mammography (FFDM) market, 2021 - 2030 (USD Million) 8.3.1.1.2. Analog Mammography market, 2021 - 2030 (USD Million) 8.3.1.1.3 3D Breast Tomosynthesis market, 2021 - 2030 (USD Million) 8.3.1.2. Molecular Breast Imaging (MBI) market, 2021 - 2030 (USD Million) 8.3.1.3. Positron Emission Tomography-Computed Tomography (PET-CT) market, 2021 - 2030 (USD Million) 8.3.1.4. Cone-beam Computed Tomography (CBCT) market, 2021 - 2030 (USD Million) 8.3.1.5. Positron Emission Mammography (PEM) market, 2021 - 2030 (USD Million) 8.4. Non-ionizing Breast Imaging 8.4.1. Non-ionizing Market, 2021 - 2030 (USD Million) 8.4.1.1. Breast Ultrasound market, 2021 - 2030 (USD Million) 8.4.1.2. Automated whole-breast Ultrasound (AWBU) market, 2021 - 2030 (USD Million) 8.4.1.3. Breast MRI market, 2021 - 2030 (USD Million) 8.4.1.4. Electric Impedance Tomography market, 2021 - 2030 (USD Million) 8.4.1.5. Breast thermography market, 2021 - 2030 (USD Million) 8.4.1.6. Optical Imaging market, 2021 - 2030 (USD Million) 9. Global Market: Regional Outlook 9.1 North America 9.1.1. North America Market, By End-User, 2021 - 2030 (USD Million) 9.1.4. North America Market, By Technology, 2021 - 2030 (USD Million) 9.1.5. North America Market, by Country, 2021 - 2030 (USD Million) 9.1.4.1. U.S. 9.1.4.1.1. U.S. Market, By End-User, 2021 - 2030 (USD Million) 9.1.4.2. Canada 9.1.4.2.1. Canada Market, By End-User, 2021 - 2030 (USD Million) 9.1.4.2.2. Canada Market, By Region, 2021 - 2030 (USD Million) 9.1.4.2.3. Canada Market, by Technology, 2021 - 2030 (USD Million) 9.2. Europe 9.2.1. Europe Market, By End-User, 2021 - 2030 (USD Million) 9.2.2. Europe Market, by By Technology, 2021 - 2030 (USD Million) 9.2.5. Europe Market, by country, 2021 - 2030 (USD Million) 9.2.4.1 U.K. 9.2.4.1.1. U.K. Market, By End-User, 2021 - 2030 (USD Million) 9.2.4.1.2. U.K. Market, By Technologys, 2021 - 2030 (USD Million) 9.2.4.1.3. U.K. Market, by Region, 2021 - 2030 (USD Million) 9.2.4.2. Germany 9.2.4.2.1. Germany Market, By End-User, 2021 - 2030 (USD Million) 9.2.4.2.2. Germany Market, By Technology, 2021 - 2030 (USD Million) 9.2.4.2.3. Germany Market, by Region, 2021 - 2030 (USD Million) 9.2.4.3. France 9.2.4.3.1. France Market, By End-User, 2021 - 2030 (USD Million) 9.2.4.3.2. France Market, By Region, 2021 - 2030 (USD Million) 9.2.4.3.3. France Market, by Technology, 2021 - 2030 (USD Million) 9.2.4.4. Rest of Europe 9.2.4.4.1. Rest of Europe Market, By End-User, 2021 - 2030 (USD Million) 9.2.4.4.2. Rest of Europe Market, By Region, 2021 - 2030 (USD Million) 9.2.4.4.3. Rest of Europe Market, by Technology, 2021 - 2030 (USD Million) 9.3. Asia Pacific 9.3.1. Asia Pacific Market, By End-User, 2021 - 2030 (USD Million) 9.3.2. Asia Pacific Market, By Technology, 2021 - 2030 (USD Million) 9.3.5. Asia Pacific Market, by country, 2021 - 2030 (USD Million) 9.3.4.1. China 9.3.4.1.1. China Market, By End-User, 2021 - 2030 (USD Million) 9.3.4.1.2. China Market, By Region, 2021 - 2030 (USD Million) 9.3.4.1.3. China Market, by Technology, 2021 - 2030 (USD Million) 9.3.4.2. India 9.3.4.2.1. India Market, By End-User, 2021 - 2030 (USD Million) 9.3.4.2.2. India Market, By Region, 2021 - 2030 (USD Million) 9.3.4.2.3. India Market, by Technology, 2021 - 2030 (USD Million) 9.3.4.3. Japan 9.3.4.3.1. Japan Market, By End-User, 2021 - 2030 (USD Million) 9.3.4.3.3. Japan Market, by Technology, 2021 - 2030 (USD Million) 9.3.4.4. South Korea 9.3.4.4.1. South Korea Market, By End-User, 2021 - 2030 (USD Million) 9.3.4.4.3. South Korea Market, by Technology, 2021 - 2030 (USD Million) 9.3.4.5. Rest of ASIA PACIFIC 9.3.4.5.1. Rest of ASIA PACIFIC Market, By End-User, 2021 - 2030 (USD Million) 9.3.4.5.3. Rest of ASIA PACIFIC Market, by Technology, 2021 - 2030 (USD Million) 9.4. Latin America 9.4.1. Latin America Market, By End-User, 2021 - 2030 (USD Million) 9.4.3. Latin America Market, by Technology, 2021 - 2030 (USD Million) 9.4.4. Latin America Market, by country, 2021 - 2030 (USD Million) 9.4.4.1. Brazil 9.4.4.1.1. Brazil Market, By End-User, 2021 - 2030 (USD Million) 9.4.4.1.3. Brazil Market, by Technology, 2021 - 2030 (USD Million) 9.4.4.2. Mexico 9.4.4.2.1. Mexico Market, By End-User, 2021 - 2030 (USD Million) 9.4.4.2.3. Mexico Market, by Technology, 2021 - 2030 (USD Million) 9.4.4.3. Rest of the Latin America 9.4.4.3.1. Rest of the Latin America Market, By End-User, 2021 - 2030 (USD Million) 9.4.4.3.3. Rest of the Latin America Market, by Technology, 2021 - 2030 (USD Million) 10. Competitive Landscape 10.1 Hologic Inc. 10.1.1. Company overview 10.1.2. Financial performance 10.1.3. Technology Portfolio Analysis 10.1.4. Business Strategy & Recent Development 10.2. Siemens Healthineers 10.2.1. Company overview 10.2.2. Financial performance 10.2.3. Technology Portfolio Analysis 10.2.4. Business Strategy & Recent Development 10.3. GE Healthcare. 10.3.1. Company overview 10.3.2. Financial performance 10.3.3. Technology Portfolio Analysis 10.3.4. Business Strategy & Recent Development 10.4. Fujifilm Holdings Corporation. 10.4.1. Company overview 10.4.2. Financial performance 10.4.3. Technology Portfolio Analysis 10.4.4. Business Strategy & Recent Development 10.5. Canon Inc. 10.5.1. Company overview 10.5.2. Financial performance 10.5.3. Technology Portfolio Analysis 10.5.4. Business Strategy & Recent Development 10.6. Koninklijke Philips N.V. 10.6.1. Company overview 10.6.2. Financial performance 10.6.3. Technology Portfolio Analysis 10.6.4. Business Strategy & Recent Development 10.7. Aurora Healthcare US Corp. 10.7.1. Company overview 10.7.2. Financial performance 10.7.3. Technology Portfolio Analysis 10.7.4. Business Strategy & Recent Development 10.8. Allengers. 10.8.1. Company overview 10.8.2. Financial performance 10.8.3. Technology Portfolio Analysis 10.8.4. Business Strategy & Recent Development 10.9. Dilon Technologies, Inc. 10.9.1. Company overview 10.9.2. Financial performance 10.9.3. Product Portfolio Analysis 10.9.4. Business Strategy & Recent Development 10.10. Planmed Oy. 10.10.1. Company overview 10.10.2. Financial performance 10.10.3. Product Portfolio Analysis 10.10.4. Business Strategy & Recent Development 10.11. Delphinus Medical Technologies Inc. 10.11.1. Company overview 10.11.2. Financial performance 10.11.3. Product Portfolio Analysis 10.11.4. Business Strategy & Recent Development 10.12. CMR Naviscan Corporation. 10.12.1. Company overview 10.12.2. Financial performance 10.12.3. Product Portfolio Analysis 10.12.4. Business Strategy & Recent Development 10.13. Micrima Limited. 10.13.1. Company overview 10.13.2. Financial performance 10.13.3. Product Portfolio Analysis 10.13.4. Business Strategy & Recent Development 10.14. SuperSonic Imagine. 10.14.1. Company overview 10.14.2. Financial performance 10.14.3. Product Portfolio Analysis 10.14.4. Business Strategy & Recent Development 10.15. Carestream Health. 10.15.1. Company overview 10.15.2. Financial performance 10.15.3. Product Portfolio Analysis 10.15.4. Business Strategy & Recent Development List of Tables (67 Tables) TABLE 1. Market, By End-User, 2021-2030 (USD Million) TABLE 2. Market FOR Hospitals & Clinics, BY REGION, 2021-2030 (USD Million) TABLE 3. Market FOR Diagnostic Imaging Centers, BY REGION, 2021-2030 (USD Million) TABLE 5. Market FOR Breast Care Centers, BY REGION, 2021-2030 (USD Million) TABLE 6. Market, BY TECHNOLOGY, 2021-2030 (USD Million) TABLE 7. Market FOR Ionizing Breast Imaging, BY REGION, 2021-2030 (USD Million) TABLE 8. Market FOR Mammography, BY REGION, 2021-2030 (USD Million) TABLE 9. Market FOR Full-field Digital Mammography (FFDM), BY REGION, 2021-2030 (USD Million) TABLE 10. Market FOR Analog Mammography, BY REGION, 2021-2030 (USD Million) TABLE 11. Market FOR 3D Breast Tomosynthesis, BY REGION, 2021-2030 (USD Million) TABLE 12. Market FOR Molecular Breast Imaging (MBI), BY REGION, 2021-2030 (USD Million) TABLE 13. Market FOR Positron Emission Tomography-Computed Tomography (PET-CT), BY REGION, 2021-2030 (USD Million) TABLE 14. Market FOR Cone-beam Computed Tomography (CBCT), BY REGION, 2021-2030 (USD Million) TABLE 15. Market FOR Positron Emission Mammography (PEM), BY REGION, 2021-2030 (USD Million) TABLE 16. Market FOR Non-ionizing Breast Imaging, BY REGION, 2021-2030 (USD Million) TABLE 17. Market FOR Breast Ultrasound, BY REGION, 2021-2030 (USD Million) TABLE 18. Market FOR Automated whole-breast Ultrasound (AWBU), BY REGION, 2021-2030 (USD Million) TABLE 19. Market FOR Breast MRI, BY REGION, 2021-2030 (USD Million) TABLE 20. Market FOR Electric Impedance Tomography, BY REGION, 2021-2030 (USD Million) TABLE 21. Market FOR Breast thermography, BY REGION, 2021-2030 (USD Million) TABLE 22. Market FOR Optical Imaging, BY REGION, 2021-2030 (USD Million) TABLE 23. Market, BY REGION, 2021-2030 (USD Million) TABLE 24. NORTH AMERICA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 25. NORTH AMERICA Market, BY Technologys, 2021-2030 (USD Million) TABLE 26. NORTH AMERICA Market, By End-User, 2021-2030 (USD Million) TABLE 27. NORTH AMERICA Market, BY TECHNOLOGY, 2021-2030 (USD Million) TABLE 28. EUROPE Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 29. EUROPE Market, By End-User, 2021-2030 (USD Million) TABLE 30. EUROPE Market, BY TECHNOLOGY, 2021-2030 (USD Million) TABLE 32. ASIA-PACIFIC Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 33. ASIA-PACIFIC Market, By End-User, 2021-2030 (USD Million) TABLE 34. ASIA-PACIFIC Market, BY TECHNOLOGY, 2021-2030 (USD Million) TABLE 35. LAMEA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 36. LAMEA Market, By End-User, 2021-2030 (USD Million) TABLE 37. LAMEA Market, BY TECHNOLOGY, 2021-2030 (USD Million) TABLE 38. Hologic Inc: COMPANY SNAPSHOT TABLE 39. Hologic Inc: OPERATING SEGMENTS TABLE 40. Siemens Healthineers: COMPANY SNAPSHOT TABLE 41. Siemens Healthineers: OPERATING SEGMENTS TABLE 42. GE Healthcare: COMPANY SNAPSHOT TABLE 43. GE Healthcare: OPERATING SEGMENTS TABLE 44. Fujifilm Holdings Corporation: COMPANY SNAPSHOT TABLE 45. Fujifilm Holdings Corporation: OPERATING SEGMENTS TABLE 46. Canon Inc: COMPANY SNAPSHOT TABLE 47. Canon Inc: OPERATING SEGMENTS TABLE 48. Koninklijke Philips N.V.: COMPANY SNAPSHOT TABLE 49. Koninklijke Philips N.V.: OPERATING SEGMENTS TABLE 50. Aurora Healthcare US Corp: COMPANY SNAPSHOT TABLE 51. Aurora Healthcare US Corp: OPERATING SEGMENTS TABLE 52. Allengers: COMPANY SNAPSHOT TABLE 53. Allengers: OPERATING SEGMENTS TABLE 54. Dilon Technologies, Inc: COMPANY SNAPSHOT TABLE 55. Dilon Technologies, Inc: OPERATING SEGMENTS TABLE 56. Planmed Oy: COMPANY SNAPSHOT TABLE 57. Planmed Oy: OPERATING SEGMENTS TABLE 58. Delphinus Medical Technologies Inc: COMPANY SNAPSHOT TABLE 59. Delphinus Medical Technologies Inc: OPERATING SEGMENTS TABLE 60. CMR Naviscan Corporation: COMPANY SNAPSHOT TABLE 61. CMR Naviscan Corporation: OPERATING SEGMENTS TABLE 62. Micrima Limited: COMPANY SNAPSHOT TABLE 63. Micrima Limited: OPERATING SEGMENTS TABLE 64. SuperSonic Imagine: COMPANY SNAPSHOT TABLE 65. SuperSonic Imagine: OPERATING SEGMENTS TABLE 66. Carestream Health: COMPANY SNAPSHOT TABLE 67. Carestream Health: OPERATING SEGMENTS List of Figures (20 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Technology-Based Estimation